However, since rapamycin elevated viral ORF1A by 400-fold but only increased cellular IL6 and IFNB1 by 2.5-fold or less, these results suggest that rapamycin increased cellular susceptibility to SARS-CoV-2 infection, while limiting inflammatory cytokine induction in response to infection. The gene discussed is IFNB1; the disease is infection.